Home > Keywords >
| Catalog | name | Description | price |
|---|---|---|---|
| R-XASYS-00452 | 1-Phenylcarbamoyl-5-fluoroureacil,cas:56563-17-8 | 1-Phenylcarbamoyl-5-fluoroureacil(C11H8FN3O3,249.2) is a chemical compound that is used in research. It has an IC50 of 0.4 μM for inhibition of the enzyme cyclic guanosine monophosphate (cGMP) phosphodiesterase type 5 (PDE5). 1-Phenylcarbamoyl-5-fluoroureacil is a potent activator of ion channels and ligands for receptors. | price> |
| R-R-0452 | Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester | Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester is a click chemistry reagent, itcontains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups. | price> |
| R-Mcs-452 | L-a-PC:Chol:DPPE-N-dbco:Fluorescent Lipid Pyrene lipid(headgroup)(68.5:30:1:0.5molar ratio) | L-a-PC:Chol:DPPE-N-dbco:Fluorescent Lipid Pyrene lipid (headgroup)(68.5:30:1:0.5molar ratio) is a type of lipid nanocomposite material. Applications: Targeted liposome design via azide–DBCO click chemistry. Fluorescently trackable drug delivery systems. In vitro and in vivo imaging of liposomal behavior. | price> |
| R-XASYS-00453 | NS 638,cas:150493-34-8 | NS 638(C15H11ClF3N3,325.7) is an inhibitor of the N-type voltage-gated calcium channel Cav2.2 and CNS L-type calcium channels.It inhibits potassium-induced calcium uptake in chick cortical synaptosomes (IC50 = 3.4 µM) and AMPA-induced GABA release from primary chick cortical neurons (IC50 = 4.3 µM). | price> |
| R-R-0453 | Gly-Gly-Gly-PEG4-methyltetrazine | Gly-Gly-Gly-PEG4-methyltetrazine/CAS: 2353409-82-0 is a cleavable PEG linker used in the synthesis of antibody-drug conjugates. | price> |
| R-Mcs-453 | L-a-PC:Chol:DPPE-N-dbco:Fluorescent Lipid Rhodamine lipid(headgroup)(68.5:30:1:0.5molar ratio) | L-a-PC:Chol:DPPE-N-dbco:Fluorescent Lipid Rhodamine lipid (headgroup) (68.5:30:1:0.5molar ratio) is a type of lipid nanocomposite material. Applications: Targeted liposome design via azide–DBCO click chemistry. Fluorescently trackable drug delivery systems. In vitro and in vivo imaging of liposomal behavior. | price> |
| R-XASYS-00454 | CD532,cas:1639009-81-6 | CD532(C26H25F3N8O,522.5) is an inhibitor of Aurora A kinase activity (IC50 = 48 nM) and the protein-protein interaction between N-Myc and Aurora A kinase.It also inhibits several cyclin-dependent kinases (CDKs), FGFRs, MEKs, and PDGFRs, as well as FLT3, KIT, and RET at 10 µM. | price> |
| R-R-0454 | Mal-PEG4-VA | Mal-PEG4-VA/CAS:1800456-31-8 is a type of polymer used in drug delivery and medical devices. It is a derivative of polyethylene glycol (PEG) that has been modified with a vinyl acetate (VA) group. This modification allows for better control over the release of drugs and improves the biocompatibility of the material. Mal-PEG4-VA is commonly used in the development of targeted drug delivery systems and in the creation of long-acting formulations for various medical applications. | price> |
| R-Mcs-454 | HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Azide(57:38:4:1molar ratio)Fluorescent Lipid DiA | HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Azide(57:38:4:1molar ratio)Fluorescent Lipid DiA is a multifunctional nanocarrier. Application scenarios: Drug delivery: Encapsulate hydrophobic drugs (such as paclitaxel), target tumors through EPR effect, and reduce clearance rate through PEG modification. Biological imaging: DiA labeling combined with azide functionalization achieves dual-mode imaging (fluorescence/MRI). Gene therapy: coupling siRNA or CRISPR system to promote cell transfection through DSPE-PEG membrane fusion. | price> |
| R-XASYS-00455 | 1-cyclohexyl-3-dodecylurea,cas:402939-18-8 | 1-Cyclohexyl-3-dodecylurea(C19H38N2O,310.52) is a highly selective soluble epoxide hydrolase (sEH) inhibitor. | price> |
| R-R-0455 | Azido-PEG3-Val-Cit-PAB-OH | Azido-PEG3-Val-Cit-PAB-OH-OH/CAS:2055024-65-0 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADC). The Val-Cit is specifically cleaved by cathepsin B. As this enzyme is only present in the lysosome the ADC payload will be release only in the cell. The Boc group can be deprotected under acidic conditions to generate a free amine group. | price> |
| R-Mcs-455 | HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Azide(57:38:4:1molar ratio)Fluorescent Lipid DiD | HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Azide(57:38:4:1molar ratio)Fluorescent Lipid DiD The composite system is a multifunctional nanocarrier designed to combine the membrane fusion ability of phospholipids, the stability of cholesterol, the long cycling properties of PEG, and the click chemistry activity of azide groups, making it suitable for biomedical applications such as drug delivery and bioimaging. | price> |
| R-Y-3501 | 9-mesityl-10-phenylacridin-10-ium tetrafluoroborate | 9-mesityl-10-phenylacridin-10-ium tetrafluoroborate is provided by Ruixi biological Co,Ltd.It has stable characteristics,does not polymerize,is insoluble in water,and soluble in ethanol,ether,benzene,ketone,carbon tetrachloride,petroleum ether,etc | price> |
| R-XASYS-00456 | Donepezil N-oxide,cas:120013-84-5 | Donepezil N-oxide(C24H29NO4,395.5) is an active metabolite of the acetylcholinesterase inhibitor donepezil.Donepezil N-oxide inhibits cholinesterase (ChE) activity in human erythrocytes in a concentration-dependent manner, exhibiting 45.5% inhibition when used at a concentration of 20 µM. | price> |
| R-R-0456 | Azido-PEG3-Val-Cit-PAB-PNP | Azido-PEG3-Val-Cit-PAB-PNP/CAS:2055047-18-0 is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).Azido-PEG3-Val-Cit-PAB-PNP is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. | price> |
| R-Mcs-456 | HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Azide(57:38:4:1molar ratio)Fluorescent Lipid DiI | HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Azide(57:38:4:1molar ratio)Fluorescent Lipid DiI is a DiI-labeled PEGylated liposomal formulation incorporating azide-functionalized PEG-lipid for post-modification via click chemistry. Applications: Bio-orthogonal targeted liposomes (via azide-alkyne click reactions). Fluorescence-tracked delivery systems. Cellular binding and uptake studies. In vitro / in vivo imaging and biodistribution mapping. | price> |
| R-Y-3502 | 9-mesityl-10-phenylacridin-10-ium hydrochloride | 9-mesityl-10-phenylacridin-10-ium hydrochloride is provided by Ruixi biological Co,Ltd.It has stable characteristics,non polymerization,insoluble in water,soluble in ethanol,ether,benzene,ketone,carbon tetrachloride,petroleum ether,etc.Ruixi can provide customized services. | price> |
| R-XASYS-00457 | 10-DEBC HCl,cas:925681-41-0 | 10-Deoxy-10-β-D-arabinofuranosylcytosine (10-DEBC)(C20H25ClN2O•HCl,381.3) is a chemotherapeutic drug that is used to treat cancers and degenerative diseases. 10-DEBC is an analog of deoxycytidine and it inhibits the synthesis of DNA by competitively inhibiting the ATP binding cassette transporter, leading to cell death by apoptosis or autophagy. | price> |
| R-R-0457 | Gly-PEG3-amine | Gly-PEG3-amine/Cas.2110448-97-8/Gly-PEG3-amine, TFA salt is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | price> |
| R-Mcs-457 | HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Azide(57:38:4:1molar ratio)Fluorescent Lipid DiO | HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Azide(57:38:4:1molar ratio)Fluorescent Lipid DiO is a functionalized liposome/micelle system used for nanomedicine delivery or bioimaging. Application scenarios: Targeted drug delivery: The azide group can be linked to targeted peptides (such as RGD or HA) through a click reaction to achieve lesion specific enrichment. Fluorescence imaging:Green fluorescence of DiO (excitation/emission wavelength: 484/501 nm) can be used to track carrier dynamics at the in vivo or cellular level. Drug encapsulation: Hydrophobic drugs can be embedded in lipid bilayers, while hydrophilic drugs can be loaded through the internal aqueous phase, with an encapsulation efficiency of over 80%. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


